adMare BioInnovations
Edie Dullaghan has a strong background in the biotechnology and pharmaceutical industry with experience in both research and leadership roles. Edie began their career in 2003 as a Senior Scientist at Inimex Pharmaceuticals, where they worked until 2007. In 2007, they joined the Centre for Drug Research and Development (CDRD) as the Head of Target Validation and also took on the role of Research Development. In these positions, they were responsible for the development of assays to identify biomarkers and execute project plans for drug development. Edie continued to work at CDRD until 2023. In the same year, they became a Member of the Board of Directors at the B.C. Tumour Foundation. Additionally, they served as the Bioinnovation Scientist Program Director and the Scientific Program Director for adMare BioInnovations, where they have been since 2007.
Edie Dullaghan BSc., PhD pursued their Doctor of Philosophy (Ph.D.) in Molecular Microbiology from 1996 to 1999 at the National Institute for Medical Research.
adMare BioInnovations
With offices in Montreal, Vancouver and Toronto, adMare is building Canada’s life science industry from sea to sea. With a strong track record of globally-competitive scientific discovery, Canada is primed to lead the life sciences world. To make this a reality, at adMare BioInnovations, we use our scientific and commercial expertise, specialized R&D infrastructure, and seed capital to build strong life sciences companies, robust ecosystems and industry-ready talent — and re-invest our returns back into the Canadian industry to ensure its long-term sustainability. www.admarebio.com Avec des bureaux situés à Montréal, Vancouver et Toronto, adMare développe le secteur canadien des sciences de la vie d’un océan à l’autre. Grâce à sa riche expérience en matière de découvertes scientifiques concurrentielles à l’échelle internationale, le Canada est prêt à devenir un chef de file mondial dans le domaine des sciences de la vie. C’est pour concrétiser cet objectif qu’adMare BioInnovations tire parti de son expertise technique et commerciale, de son infrastructure de recherche et développement spécialisée et de son capital d’investissement pour développer de solides entreprises des sciences de la vie, des écosystèmes robustes et les talents prêts à travailler dans l’industrie. Nous réinvestissons nos bénéfices dans l’industrie canadienne pour assurer son maintien à long terme. www.admarebio.com/fr